Adesola Olalekan1, Francis Onwugamba2, Bamidele Iwalokun3, Alexander Mellmann4, Karsten Becker2, Frieder Schaumburg5. 1. Department of Medical Laboratory Science, College of Medicine, University of Lagos, Lagos, Nigeria. 2. Institute of Medical Microbiology, University Hospital Münster, Domagkstraße 10, 48149 Münster, Germany. 3. Molecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Lagos, Nigeria. 4. Institute of Medical Microbiology, University Hospital Münster, Domagkstraße 10, 48149 Münster, Germany; Institute of Hygiene, University Hospital Münster, Münster, Germany. 5. Institute of Medical Microbiology, University Hospital Münster, Domagkstraße 10, 48149 Münster, Germany. Electronic address: frieder.schaumburg@ukmuenster.de.
Abstract
OBJECTIVES: Carbapenem-resistant Enterobacterales are a global problem, however little is known about the burden and origin of carbapenem resistance in Africa. The objectives of this study were to determine the proportion of carbapenem-resistant isolates among extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), to identify the underlying mechanisms of resistance and to assess the population structure of carbapenem-resistant isolates from Nigeria. METHODS: ESBL-E isolates (n = 175) from infections were collected at four hospitals in Lagos, Nigeria, from July 2016 to January 2018 and were screened for carbapenem resistance using a VITEK®2 automated system. All carbapenem-resistant ESBL-E (CRE) were screened for blaKPC, blaCTX-M, blaCMY-2, blaNDM, blaVIM, blaIMP, blaOXA-181 and blaOXA-48 genes. Genotyping of randomly selected isolates was performed by whole-genome sequencing. RESULTS: The isolates included Escherichia coli (n = 113; 64.6%) and Klebsiella pneumoniae (n = 62; 35.4%). Of the 175 ESBL-E isolates, 48 (27.4%) were resistant to carbapenems (15 E. coli and 33 K. pneumoniae). CRE isolates carried blaNDM (n = 30; 62.5%), blaNDM + blaOXA-181 (n = 10; 20.8%), blaOXA-181 (n = 2; 4.2%) and blaNDM + blaOXA-48 (n = 1; 2.1%); no carbapenemase gene was detected in 5 isolates (10.4%). The isolates showed low diversity and were mainly associated with multilocus sequence typing (MLST) sequence types ST410 for E. coli and ST395 and ST147 for K. pneumoniae. CONCLUSION: Carbapenem resistance is frequent among ESBL-E in Nigeria and is mainly associated with blaNDM. Genotyping suggested that the observed clones possibly originated from Southeast Asia.
OBJECTIVES:Carbapenem-resistant Enterobacterales are a global problem, however little is known about the burden and origin of carbapenem resistance in Africa. The objectives of this study were to determine the proportion of carbapenem-resistant isolates among extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), to identify the underlying mechanisms of resistance and to assess the population structure of carbapenem-resistant isolates from Nigeria. METHODS: ESBL-E isolates (n = 175) from infections were collected at four hospitals in Lagos, Nigeria, from July 2016 to January 2018 and were screened for carbapenem resistance using a VITEK®2 automated system. All carbapenem-resistant ESBL-E (CRE) were screened for blaKPC, blaCTX-M, blaCMY-2, blaNDM, blaVIM, blaIMP, blaOXA-181 and blaOXA-48 genes. Genotyping of randomly selected isolates was performed by whole-genome sequencing. RESULTS: The isolates included Escherichia coli (n = 113; 64.6%) and Klebsiella pneumoniae (n = 62; 35.4%). Of the 175 ESBL-E isolates, 48 (27.4%) were resistant to carbapenems (15 E. coli and 33 K. pneumoniae). CRE isolates carried blaNDM (n = 30; 62.5%), blaNDM + blaOXA-181 (n = 10; 20.8%), blaOXA-181 (n = 2; 4.2%) and blaNDM + blaOXA-48 (n = 1; 2.1%); no carbapenemase gene was detected in 5 isolates (10.4%). The isolates showed low diversity and were mainly associated with multilocus sequence typing (MLST) sequence types ST410 for E. coli and ST395 and ST147 for K. pneumoniae. CONCLUSION:Carbapenem resistance is frequent among ESBL-E in Nigeria and is mainly associated with blaNDM. Genotyping suggested that the observed clones possibly originated from Southeast Asia.
Authors: Kabiru O Akinyemi; Rebecca O Abegunrin; Bamidele A Iwalokun; Christopher O Fakorede; Oliwia Makarewicz; Heinrich Neubauer; Mathias W Pletz; Gamal Wareth Journal: Antibiotics (Basel) Date: 2021-02-01
Authors: Ayorinde O Afolayan; Anderson O Oaikhena; Aaron O Aboderin; Olatunde F Olabisi; Adewale A Amupitan; Oyekola V Abiri; Veronica O Ogunleye; Erkison Ewomazino Odih; Abolaji T Adeyemo; Adeyemi T Adeyemo; Temitope O Obadare; Monica Abrudan; Silvia Argimón; Sophia David; Mihir Kekre; Anthony Underwood; Abiodun Egwuenu; Chikwe Ihekweazu; David M Aanensen; Iruka N Okeke Journal: Clin Infect Dis Date: 2021-12-01 Impact factor: 9.079
Authors: James A Karlowsky; Samuel K Bouchillon; Ramy El Mahdy Kotb; Naglaa Mohamed; Gregory G Stone; Daniel F Sahm Journal: JAC Antimicrob Resist Date: 2022-06-17
Authors: Frieder Schaumburg; Jonathan Vas Nunes; Giulia Mönnink; Abdul-Mac Falama; James Bangura; Hanna Mathéron; Amara Conteh; Maxwell Sesay; Aminata Sesay; Martin P Grobusch Journal: Infection Date: 2022-02-23 Impact factor: 7.455
Authors: A Olowo-Okere; Y K E Ibrahim; B O Olayinka; J O Ehinmidu; Y Mohammed; L Z Nabti; J-M Rolain; S M Diene Journal: New Microbes New Infect Date: 2020-08-01
Authors: Sophie Roth; Fabian K Berger; Andreas Link; Anna Nimmesgern; Philipp M Lepper; Niels Murawski; Jörg T Bittenbring; Sören L Becker Journal: Eur J Clin Microbiol Infect Dis Date: 2020-09-07 Impact factor: 3.267